Soursop Phytocompounds as Potential Anticancer Agents: A Molecular Docking Study

Authors

  • Aparna B Murukan

DOI:

https://doi.org/10.37591/rrjocb.v12i3.3371

Keywords:

Soursop, Antiapoptotic protein, Annona muricata Lin, Bcl-2, Mcl-1, Molecular docking, ADMET.

Abstract

Objective: According to tumor statistics, there will be a total of approximately 1,958,310 new malignancy cases, that balances to nearly 5,370 cases day by day. Without any questions its clearly evident that cancer is considered as one of the deadliest diseases of mankind. The course of this study emphasizes on computational approach for finding new drug for potential target proteins Bcl-2 (4MAN) and Mcl-1(5FDO) by docking against soursop (Annona Muricata Lin) phytocompound. Thereby elucidating its potential to act as inhibitor against antiapoptotic proteins. Methods: This study mainly focusing on computational approach for evaluating the inhibitory potential of phytocompound against target proteins. The molecular docking was conducted methodically using IMPAAT for retrieving phytocompounds and plant parts, PubChem for obtaining canonical smiles, PDB to get structure of protein, BIOVIA Discovery Studio in order for visualization, PDB sum for analysis of secondary structure, ADMETlab 2.0, SwissADME for checking ADMET properties of phytocompounds and PyRx software to conducting molecular docking. Results: The docking result made known that the particular phytocompound as ligand shows the best binding affinity with target proteins. The success of phytocompound by showing best binding affinity ensure its role as a lead compound for further studies. Conclusion: The potential of traditional medicines such as phytocompounds should be further studied in order to create drug which have limited side effects.

References

Moghadamtousi S, Fadaeinasab M, Nikzad S, Mohan G, Ali H, Kadir H. Annona muricata (Annonaceae): A review of its traditional uses, isolated acetogenins and biological activities. Int J Mol Sci. 2015;16(7):15625–58. Available from: https://pubmed.ncbi.nlm.nih.gov/26184167/

Mutakin M, Fauziati R, Fadhilah FN, Zuhrotun A, Amalia R, Hadisaputri YE. Pharmacological Activities of Soursop (Annona muricata Lin.). Molecules. 2022 ;27(4):1201. Available from: https://pubmed.ncbi.nlm.nih.gov/35208993/

Mohamad Rosdi MN, Mohd Arif S, Abu Bakar MH, Razali SA, Mohamed Zulkifli R, Ya’akob H. Molecular docking studies of bioactive compounds from Annona muricata Linn as potential inhibitors for Bcl-2, Bcl-w and Mcl-1 antiapoptotic proteins. Apoptosis. 2018 23(1):27–40. Available from: https://pubmed.ncbi.nlm.nih.gov/29204721/

Ilango S, Sahoo DK, Paital B, Kathirvel K, Gabriel JI, Subramaniam K, et al. A Review on Annona muricata and Its Anticancer Activity. Cancers (Basel). 2022 ;14(18):4539. Available from: http://dx.doi.org/10.3390/cancers14184539

Yajid AI, Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia, Ab Rahman HS, Pak Kai MW, Wan Zain WZ, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia, et al. Potential Benefits of Annona muricata in Combating Cancer: A Review. Malays J Med Sci. 2018 25(1):5–15. Available from: http://dx.doi.org/10.21315/mjms2018.25.1.2

Rady I, Bloch MB, Chamcheu R-CN, Banang Mbeumi S, Anwar MR, Mohamed H, et al. Anticancer properties of graviola (Annona muricata): A comprehensive mechanistic review. Oxid Med Cell Longev. 2018 2018:1–39. Available from: http://dx.doi.org/10.1155/2018/1826170

Syed Najmuddin SUF, Romli MF, Hamid M, Alitheen NB, Nik Abd Rahman NMA. Anti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell line. BMC Complement Altern Med. 2016 16(1). Available from: https://pubmed.ncbi.nlm.nih.gov/27558166/

Ranjan A, Ramachandran S, Gupta N, Kaushik I, Wright S, Srivastava S, et al. Role of phytochemicals in cancer prevention. Int J Mol Sci. 2019 ;20(20):4981. Available from: http://dx.doi.org/10.3390/ijms20204981

Shimizu S, Eguchi Y, Kamiike W, Itoh Y, Hasegawa J, Yamabe K, et al. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res [Internet]. 1996 ;56(9). Available from: https://pubmed.ncbi.nlm.nih.gov/8616866/

Chen B-H, Chang H-W, Huang H-M, Chong I-W, Chen J-S, Chen C-Y, et al. (−)-anonaine induces DNA damage and inhibits growth and migration of human lung carcinoma H1299 cells. J Agric Food Chem. 2011 59(6):2284–90. Available from: https://pubmed.ncbi.nlm.nih.gov/21361287/

De Sousa OV, Vieira GD-V, De Pinho J de JRG, Yamamoto CH, Alves MS. Antinociceptive and anti-inflammatory activities of the ethanol extract of Annona muricata L. leaves in animal models. Int J Mol Sci. 2010 11(5):2067–78. Available from: https://pubmed.ncbi.nlm.nih.gov/20559502/

Downloads

Published

2024-02-17

Issue

Vol. 12 No. 3 (2023)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.